HDL/ApoA-1 infusion and ApoA-1 gene therapy in atherosclerosis
The HDL hypothesis stating that simply raising HDL cholesterol (HDL-C) may produce cardiovascular benefits has been questioned recently based on several randomized clinical trials using CETP inhibitors or niacin to raise HDL-C levels. However extensive pre-clinical data support the vascular protect...
Shranjeno v:
| Principais autores: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2015-09-01
|
| Serija: | Frontiers in Pharmacology |
| Teme: | |
| Online dostop: | http://journal.frontiersin.org/Journal/10.3389/fphar.2015.00187/full |
| Oznake: |
Brez oznak, prvi označite!
|